An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors
=========================================================================================================================

* Kirsty Taylor
* Helen Loo Yau
* Ankur Chakravarthy
* Ben Wang
* Shu Yi Shen
* Ilias Ettayebi
* Charles A Ishak
* Philippe L Bedard
* Albiruni Abdul Razak
* Aaron R Hansen
* Anna Spreafico
* Dave Cescon
* Marcus O Butler
* Amit M Oza
* Stephanie Lheureux
* Neda Stjepanovic
* Brendan Van As
* Sarah Boross-Harmer
* Lisa Wang
* Trevor J Pugh
* Pamela S Ohashi
* Lillian L Siu
* Daniel D De Carvalho